Long-Term Safety and Efficacy of Adalimumab in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis-Reference-Cited by-同舟云学术

Long-Term Safety and Efficacy of Adalimumab in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis

Published:2021-06 Issue:6 Volume:128 Page:899-909
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Suhler Eric B.,Jaffe Glenn J.,Fortin Eric^ORCID,Lim Lyndell L.^ORCID,Merrill Pauline T.^ORCID,Dick Andrew D.^ORCID,Brezin Antoine P.,Nguyen Quan Dong,Thorne Jennifer E.,Van Calster Joachim,Cimino Luca,Adan Alfredo,Goto Hiroshi,Kaburaki Toshikatsu^ORCID,Kramer Michal^ORCID,Vitale Albert T.,Kron Martina,Song Alexandra P.^ORCID,Liu Jianzhong,Pathai Sophia,Douglas Kevin M.,Schlaen Ariel^ORCID,Muccioli Cristina,Van Velthoven Mirjam E.J.,Zierhut Manfred,Rosenbaum James T.

Funder

AbbVie

Publisher

Elsevier BV

Subject

Ophthalmology

Reference18 articles.

1. Risk of ocular complications in patients with noninfectious intermediate uveitis, posterior uveitis, or panuveitis;Dick;Ophthalmology,2016

2. Periocular corticosteroid injections in uveitis: effects and complications;Sen;Ophthalmology,2014

3. Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis;Miloslavsky;Ann Rheum Dis,2017

4. Systemic corticosteroid therapy—side effects and their management;Stanbury;Br J Ophthalmol,1998

5. Degree, duration, and causes of visual loss in uveitis;Durrani;Br J Ophthalmol,2004

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Uveitis Patients on Anti-TNF Agents Who Develop Demyelinating Disease – A Case Series;Journal of Ophthalmic Inflammation and Infection;2024-07-30

2. Targeting inflammasomes and pyroptosis in retinal diseases—molecular mechanisms and future perspectives;Progress in Retinal and Eye Research;2024-07

3. Uveitis in the Pediatric Population and Therapeutic Management: A Current Literature Review;Children;2024-06-25

4. Hydroxychloroquine in the treatment of sarcoidosis-associated uveitis and idiopathic uveitis;2024-06-14

5. Phage Display as a Medium for Target Therapy Based Drug Discovery, Review and Update;Molecular Biotechnology;2024-06-01